Skip to main content

Valvular Heart Disease Modifies Diastolic Assessment Parameters

Valvular Heart Disease Modifies Diastolic Assessment Parameters

Diastolic function assessment by echocardiography is an essential component of cardiovascular evaluation, particularly in patients with dyspnea, heart failure, or structural heart disease. Standard diastolic indices such as E/A ratio, E/e′ ratio, left atrial volume, and tricuspid regurgitation velocity are widely used to estimate left ventricular filling pressures. However, the presence of valvular heart disease significantly alters these parameters and may lead to misinterpretation if standard algorithms are applied without modification.


Understanding how specific valvular lesions affect diastolic indices is therefore crucial for accurate hemodynamic interpretation.



---


Mitral Annular Calcification (MAC)


Mitral annular calcification is a degenerative process characterized by calcium deposition at the mitral annulus. It is commonly seen in elderly patients and those with chronic kidney disease, hypertension, and diabetes.


Key Mechanism


MAC restricts mitral annular motion, which directly affects tissue Doppler measurements. Since the e′ velocity reflects longitudinal relaxation of the myocardium and annular movement, heavy calcification can falsely reduce e′. As a result, the E/e′ ratio may appear elevated even when left atrial pressure is normal.


Because of this limitation, E/e′ becomes unreliable for estimating filling pressures in patients with significant MAC.


Diagnostic Approach


Instead of relying primarily on E/e′, transmitral inflow patterns and IVRT become more helpful.


• E/A < 0.8 suggests normal left atrial pressure.

• E/A > 1.8 suggests elevated left atrial pressure.

• If E/A lies between 0.8 and 1.8, IVRT should be used for further clarification.


Interpretation using IVRT:


• IVRT ≥ 80 ms suggests normal filling pressure.

• IVRT < 80 ms suggests elevated filling pressure.


Thus, transmitral flow dynamics and relaxation timing become the key tools for evaluation in MAC.



---


Mitral Regurgitation (MR)


Mitral regurgitation creates a state of chronic volume overload. During diastole, the left ventricle receives blood from both the left atrium and the regurgitant volume that returned during systole.


Pathophysiological Effect


This increased preload exaggerates early diastolic filling (E wave). As a result, the transmitral E velocity becomes elevated even if intrinsic diastolic function is normal. Therefore, parameters like E/A ratio may falsely mimic restrictive physiology.


In addition, left atrial pressure and size are often increased due to chronic regurgitant volume.


Reliable Parameters in MR


Certain parameters remain more reliable for assessing filling pressures:


Ar–A Duration Difference


Pulmonary vein atrial reversal duration exceeding mitral A duration by ≥30 ms suggests elevated LV filling pressure.


Isovolumic Relaxation Time (IVRT)


• IVRT < 60 ms suggests elevated left atrial pressure.


IVRT / TE–e′ Ratio


A ratio < 5.6 is associated with elevated filling pressure.


Depressed LV Function


In patients with reduced ejection fraction, an average E/e′ > 14 still retains diagnostic value for elevated filling pressures.


Therefore, integrated assessment with pulmonary venous flow, IVRT, and ventricular function is essential in MR.



---


Mitral Stenosis (MS)


Mitral stenosis produces obstruction to diastolic inflow from the left atrium to the left ventricle. Because of this mechanical obstruction, the transmitral gradient dominates the diastolic filling pattern.


Impact on Diastolic Assessment


In MS, transmitral velocities primarily reflect the severity of valve obstruction rather than ventricular relaxation or compliance. Consequently, the conventional diastolic algorithm cannot be applied reliably.


Indicators of Increased Left Atrial Pressure


Certain parameters can still provide useful information regarding filling pressure:


IVRT


• IVRT < 60 ms suggests elevated left atrial pressure.


Mitral A Velocity


• Mitral A velocity > 1.5 m/s indicates increased atrial pressure and strong atrial contraction against an obstructed valve.


IVRT / TE–e′ Ratio


• A value < 4.2 is associated with elevated filling pressures.


Because mitral stenosis primarily affects atrial-to-ventricular flow, hemodynamic interpretation should always consider valve area, transmitral gradient, and pulmonary pressures along with these indices.



---


Aortic Valve Disease (Aortic Regurgitation and Aortic Stenosis)


Aortic valve disease influences diastolic function through pressure overload (aortic stenosis) or volume overload (aortic regurgitation).


Aortic Regurgitation (AR)


Chronic AR leads to progressive left ventricular volume overload and eccentric hypertrophy. Over time, LV compliance decreases and diastolic dysfunction develops.


Indicators of Elevated Filling Pressure in Severe AR


Average E/e′ > 14

Left atrial reservoir strain (LARS) < 18%

Peak TR velocity > 2.8 m/s


These parameters reflect increased left atrial pressure and pulmonary pressures secondary to advanced diastolic dysfunction.


Aortic Stenosis (AS)


In AS, the left ventricle faces chronic pressure overload, leading to concentric hypertrophy. Myocardial stiffness develops early, resulting in impaired relaxation and elevated filling pressures.


Clinical Importance


Diastolic dysfunction in AS is strongly associated with worse clinical outcomes, including:


• Increased heart failure symptoms

• Reduced exercise capacity

• Higher postoperative morbidity after valve replacement


Therefore, evaluation of diastolic function is an important component of risk stratification in patients with aortic stenosis.



---


Clinical Implications


Valvular heart disease significantly modifies diastolic parameters and can lead to incorrect interpretation if conventional algorithms are applied blindly.


Important principles include:


• Always interpret diastolic parameters in the context of the underlying valve lesion.

• Recognize that E/e′ may be unreliable in MAC and severe MR.

• Use alternative indices such as IVRT, pulmonary venous flow, and atrial strain when necessary.

• Integrate multiple echocardiographic parameters rather than relying on a single measurement.


A lesion-specific approach to diastolic evaluation ensures more accurate estimation of filling pressures and better clinical decision-making.



---


Conclusion


Diastolic assessment in patients with valvular heart disease requires careful modification of standard echocardiographic algorithms. Each valve lesion alters cardiac loading conditions and affects diastolic indices differently.


Mitral annular calcification alters tissue Doppler interpretation, mitral regurgitation exaggerates transmitral inflow velocities, mitral stenosis causes mechanical obstruction to diastolic flow, and aortic valve disease leads to pressure or volume overload–related dysfunction.


A comprehensive, lesion-oriented approach allows clinicians to avoid diagnostic pitfalls and achieve more accurate hemodynamic assessment in patients with valvular heart disease.



---


Drmusmanjaved.com

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...